A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

November 25, 2025

Study Completion Date

December 15, 2025

Conditions

Healthy

Interventions

DRUG

MK-8527

Oral administration

DRUG

Moxifloxacin

Oral administration

DRUG

Placebo

Oral administration

Trial Locations (1)

Hassman Research Institute Marlton Site ( Site 0001), Marlton

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY